Next Article in Journal
Therapeutic Potential of Induced Neural Stem Cells for Parkinson’s Disease
Previous Article in Journal
Transcriptome-Wide Identification and Prediction of miRNAs and Their Targets in Paris polyphylla var. yunnanensis by High-Throughput Sequencing Analysis
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(1), 220; doi:10.3390/ijms18010220

Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells

1
Department of Immunology, Anhui Medical University, Hefei 230032, China
2
Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Academic Editors: William Chi-shing Cho and Terrence Piva
Received: 21 November 2016 / Revised: 22 December 2016 / Accepted: 15 January 2017 / Published: 22 January 2017
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
View Full-Text   |   Download PDF [2905 KB, uploaded 22 January 2017]   |  

Abstract

Past studies have shown that the Src homology 2-containing inositol 5-phosphatase 2 (SHIP2) is commonly downregulated in gastric cancer, which contributes to elevated activation of PI3K/Akt signaling, proliferation and tumorigenesis of gastric cancer cells. However, the mechanisms underlying the reduced expression of SHIP2 in gastric cancer remain unclear. While gene copy number variation analysis and exon sequencing indicated the absence of genomic alterations of SHIP2, bisulfite genomic sequencing (BGS) showed promoter hypomethylation of SHIP2 in gastric cancer cells. Analysis of transcriptional activity of SHIP2 promoter revealed Specificity protein 1 (Sp1) was responsible for the regulation of SHIP2 expression in gastric cancer cells. Furthermore, Sp1 expression, but not Sp3, was frequently downregulated in gastric cancer compared with normal gastric mucosa, which was associated with a paralleled reduction in SHIP2 levels in gastric cancer. Moreover, overexpression of Sp1 inhibited cell proliferation, induced apoptosis, suppressed cell motility and invasion in gastric cancer cells in vitro, which was, at least in part, due to transcriptional activation of SHIP2 mediated by Sp1, thereby inactivating Akt. Collectively, these results indicate that decreased expression of transcription factor Sp1 contributes to suppression of SHIP2 in gastric cancer cells. View Full-Text
Keywords: gastric cancer; SHIP2; Sp1 gastric cancer; SHIP2; Sp1
Figures

Figure 1a

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ye, Y.; Qian, X.Y.; Xiao, M.M.; Shao, Y.L.; Guo, L.M.; Liao, D.P.; Da, J.; Zhang, L.J.; Xu, J. Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells. Int. J. Mol. Sci. 2017, 18, 220.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top